Your browser doesn't support javascript.
loading
Comparison of HapMap and 1000 Genomes Reference Panels in a Large-Scale Genome-Wide Association Study.
de Vries, Paul S; Sabater-Lleal, Maria; Chasman, Daniel I; Trompet, Stella; Ahluwalia, Tarunveer S; Teumer, Alexander; Kleber, Marcus E; Chen, Ming-Huei; Wang, Jie Jin; Attia, John R; Marioni, Riccardo E; Steri, Maristella; Weng, Lu-Chen; Pool, Rene; Grossmann, Vera; Brody, Jennifer A; Venturini, Cristina; Tanaka, Toshiko; Rose, Lynda M; Oldmeadow, Christopher; Mazur, Johanna; Basu, Saonli; Frånberg, Mattias; Yang, Qiong; Ligthart, Symen; Hottenga, Jouke J; Rumley, Ann; Mulas, Antonella; de Craen, Anton J M; Grotevendt, Anne; Taylor, Kent D; Delgado, Graciela E; Kifley, Annette; Lopez, Lorna M; Berentzen, Tina L; Mangino, Massimo; Bandinelli, Stefania; Morrison, Alanna C; Hamsten, Anders; Tofler, Geoffrey; de Maat, Moniek P M; Draisma, Harmen H M; Lowe, Gordon D; Zoledziewska, Magdalena; Sattar, Naveed; Lackner, Karl J; Völker, Uwe; McKnight, Barbara; Huang, Jie; Holliday, Elizabeth G.
Afiliación
  • de Vries PS; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.
  • Sabater-Lleal M; University of Texas Health Science Center at Houston, Houston, TX, United States of America.
  • Chasman DI; Cardiovascular Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Trompet S; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
  • Ahluwalia TS; Harvard Medical School, Boston, MA, United States of America.
  • Teumer A; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Kleber ME; Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
  • Chen MH; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  • Wang JJ; Novo Nordisk Foundation Center For Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Attia JR; Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Marioni RE; Vth Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Steri M; Department of Neurology, Boston University School of Medicine, Boston, MA, United States of America.
  • Weng LC; Framingham Heart Study, Population Sciences Branch, Division of Intramural Research National Heart Lung and Blood Institute, National Institutes of Health, Framingham, MA, United States of America.
  • Pool R; Centre for Vision Research, Department of Ophthalmology, and Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Grossmann V; Public Health Stream, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.
  • Brody JA; School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.
  • Venturini C; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom.
  • Tanaka T; Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Rose LM; Queensland Brain Institute, University of Queensland, Brisbane, Australia.
  • Oldmeadow C; Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Monserrato, Cagliari, Italy.
  • Mazur J; Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, United States of America.
  • Basu S; Department of Biological Psychology, Netherlands Twin Register, VU University, Amsterdam, the Netherlands.
  • Frånberg M; EMGO+ institute, VU University & VU medical center, Amsterdam, the Netherlands.
  • Yang Q; Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Ligthart S; Department of Medicine, University of Washington, Seattle WA, United States of America.
  • Hottenga JJ; Division of Infection and Immunology, UCL, London, United Kingdom.
  • Rumley A; Department of Twin Research and Genetic Epidemiology, Kings College London, London, United Kingdom.
  • Mulas A; Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, United States of America.
  • de Craen AJ; Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
  • Grotevendt A; Public Health Stream, Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia.
  • Taylor KD; School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.
  • Delgado GE; Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Kifley A; Division of Biostatistics, University of Minnesota, Minneapolis, MN, United States of America.
  • Lopez LM; Cardiovascular Medicine Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Berentzen TL; Department of Numerical Analysis and Computer Science, Stockholm University, Stockholm, Sweden.
  • Mangino M; Framingham Heart Study, Population Sciences Branch, Division of Intramural Research National Heart Lung and Blood Institute, National Institutes of Health, Framingham, MA, United States of America.
  • Bandinelli S; Department of Biostatistics, Boston University School of Public Health, Boston, MA, United States of America.
  • Morrison AC; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands.
  • Hamsten A; Department of Biological Psychology, Netherlands Twin Register, VU University, Amsterdam, the Netherlands.
  • Tofler G; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
  • de Maat MP; Istituto di Ricerca Genetica e Biomedica, Consiglio Nazionale delle Ricerche, Monserrato, Cagliari, Italy.
  • Draisma HH; Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands.
  • Lowe GD; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
  • Zoledziewska M; Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute at Harbor/UCLA Medical Center, Torrance, CA, United States of America.
  • Sattar N; Division of Genomic Outcomes, Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, CA, United States of America.
  • Lackner KJ; Vth Department of Medicine, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Völker U; Centre for Vision Research, Department of Ophthalmology, and Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • McKnight B; Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom.
  • Huang J; Royal College of Surgeons in Ireland, Department of Psychiatry, Education and Research Centre, Beaumont Hospital, Dublin, Ireland.
  • Holliday EG; University College Dublin, UCD Conway Institute, Centre for Proteome Research, UCD, Belfield, Dublin, Ireland.
PLoS One ; 12(1): e0167742, 2017.
Article en En | MEDLINE | ID: mdl-28107422
ABSTRACT
An increasing number of genome-wide association (GWA) studies are now using the higher resolution 1000 Genomes Project reference panel (1000G) for imputation, with the expectation that 1000G imputation will lead to the discovery of additional associated loci when compared to HapMap imputation. In order to assess the improvement of 1000G over HapMap imputation in identifying associated loci, we compared the results of GWA studies of circulating fibrinogen based on the two reference panels. Using both HapMap and 1000G imputation we performed a meta-analysis of 22 studies comprising the same 91,953 individuals. We identified six additional signals using 1000G imputation, while 29 loci were associated using both HapMap and 1000G imputation. One locus identified using HapMap imputation was not significant using 1000G imputation. The genome-wide significance threshold of 5×10-8 is based on the number of independent statistical tests using HapMap imputation, and 1000G imputation may lead to further independent tests that should be corrected for. When using a stricter Bonferroni correction for the 1000G GWA study (P-value < 2.5×10-8), the number of loci significant only using HapMap imputation increased to 4 while the number of loci significant only using 1000G decreased to 5. In conclusion, 1000G imputation enabled the identification of 20% more loci than HapMap imputation, although the advantage of 1000G imputation became less clear when a stricter Bonferroni correction was used. More generally, our results provide insights that are applicable to the implementation of other dense reference panels that are under development.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estudio de Asociación del Genoma Completo / Proyecto Mapa de Haplotipos Tipo de estudio: Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Estudio de Asociación del Genoma Completo / Proyecto Mapa de Haplotipos Tipo de estudio: Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos